SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on April 7, 2021. The filing reports the consolidated financial results for the third quarter of fiscal year 2021. The Company is incorporated in Delaware and trades on the NASDAQ Global Select Market under the symbol LNDC.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that a press release containing these details (Exhibit 99.1) has been issued, but the figures themselves are not embedded in the provided text.
Material Changes
No material changes or comparative financial data are detailed in the provided text. The filing references the issuance of a press release regarding Q3 FY2021 results but does not summarize the specific variances from the prior period.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. It strictly references the attached press release for operational details.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q3 FY2021 in the referenced Exhibit 99.1 (Press Release).
- Confirm the Company name is Landec Corporation, as the input metadata incorrectly listed "LIFECORE BIOMEDICAL, INC."
- Review the full press release for any updated fiscal year guidance or liquidity updates not present in this 8-K summary.
- Check the Company's website or investor relations portal for the complete financial tables associated with the April 7, 2021 announcement.